{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:02:10Z","timestamp":1788289330473,"version":"build-2803163510"},"reference-count":71,"publisher":"American Medical Association (AMA)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,6,11]]},"DOI":"10.1001\/jama.2019.6390","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T15:57:48Z","timestamp":1560268668000},"page":"2203","source":"Crossref","is-referenced-by-count":272,"title":["Preexposure Prophylaxis for the Prevention of HIV Infection"],"prefix":"10.1001","volume":"321","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California"},{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[{"name":"Fairfax Family Practice Residency, Fairfax, Virginia"},{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cabana","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Curry","sequence":"additional","affiliation":[{"name":"University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyke A.","family":"Doubeni","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John W.","family":"Epling","sequence":"additional","affiliation":[{"name":"Virginia Tech Carilion School of Medicine, Roanoke"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"Temple University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Seth","family":"Landefeld","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Pbert","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Simon","sequence":"additional","affiliation":[{"name":"Northwestern University, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Tseng","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu"},{"name":"Pacific Health Research and Education Institute, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University, Medford, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"jus190009r5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review.","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS"},{"key":"jus190009r6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1743-6109.2010.02017.x","article-title":"Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States.","volume":"7","author":"Reece","year":"2010","journal-title":"J Sex Med"},{"issue":"8","key":"jus190009r7","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.","volume":"5","author":"Bavinton","year":"2018","journal-title":"Lancet HIV"},{"issue":"2","key":"jus190009r8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"jus190009r9","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study","author":"Rodger","journal-title":"Lancet"},{"issue":"10","key":"jus190009r10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7326\/M17-2082","article-title":"HIV incidence, prevalence, and undiagnosed infections in U.S. men who have sex with men.","volume":"168","author":"Singh","year":"2018","journal-title":"Ann Intern Med"},{"issue":"9651","key":"jus190009r11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"jus190009r12","doi-asserted-by":"publisher","first-page":"e87139","DOI":"10.1371\/journal.pone.0087139","article-title":"HIV infection and sexual risk among men who have sex with men and women (MSMW): a systematic review and meta-analysis.","volume":"9","author":"Friedman","year":"2014","journal-title":"PLoS One"},{"issue":"15","key":"jus190009r14","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","article-title":"Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.","volume":"25","author":"Mugo","year":"2011","journal-title":"AIDS"},{"issue":"11","key":"jus190009r16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamapediatrics.2017.2007","article-title":"Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States.","volume":"171","author":"Hosek","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"12","key":"jus190009r17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.7326\/M14-1965","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement.","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus190009r21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/0003-4819-159-1-201307020-00645","article-title":"Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement.","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus190009r25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"jus190009r26","doi-asserted-by":"publisher","first-page":"20903","DOI":"10.7448\/IAS.19.1.20903","article-title":"Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.","volume":"19","author":"Chan","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"jus190009r27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services.","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"46","key":"jus190009r29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition\u2014United States, 2015.","volume":"64","author":"Smith","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"jus190009r30","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annepidem.2018.06.009","article-title":"Trends in the use of oral emtricitabine\/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.","volume":"28","author":"Sullivan","year":"2018","journal-title":"Ann Epidemiol"},{"key":"jus190009r32","article-title":"Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force","author":"Chou","journal-title":"JAMA"},{"issue":"1","key":"jus190009r33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/OLQ.0000000000000535","article-title":"Are Centers for Disease Control and Prevention guidelines for preexposure prophylaxis specific enough? formulation of a personalized HIV risk score for pre-exposure prophylaxis initiation.","volume":"44","author":"Beymer","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"3","key":"jus190009r34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/cid\/civ335","article-title":"Development and validation of the San Diego Early Test Score to predict acute and early HIV infection risk in men who have sex with men.","volume":"61","author":"Hoenigl","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9","key":"jus190009r35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/OLQ.0b013e3181a9cc41","article-title":"Prediction of HIV acquisition among men who have sex with men.","volume":"36","author":"Menza","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"4","key":"jus190009r36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States.","volume":"60","author":"Smith","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"jus190009r37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/OLQ.0000000000000596","article-title":"Assessing the performance of 3 human immunodeficiency virus incidence risk scores in a cohort of black and white men who have sex with men in the South.","volume":"44","author":"Jones","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"3","key":"jus190009r38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/QAD.0000000000001710","article-title":"Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young black MSM in Chicago.","volume":"32","author":"Lancki","year":"2018","journal-title":"AIDS"},{"issue":"3","key":"jus190009r39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ADM.0000000000000123","article-title":"A brief screening tool to assess the risk of contracting HIV infection among active injection drug users.","volume":"9","author":"Smith","year":"2015","journal-title":"J Addict Med"},{"issue":"23","key":"jus190009r40","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection.","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"jus190009r41","doi-asserted-by":"publisher","first-page":"e33103","DOI":"10.1371\/journal.pone.0033103","article-title":"Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.","volume":"7","author":"Mutua","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"jus190009r42","doi-asserted-by":"publisher","first-page":"e74314","DOI":"10.1371\/journal.pone.0074314","article-title":"Safety, adherence and acceptability of intermittent tenofovir\/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.","volume":"8","author":"Kibengo","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"jus190009r43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"jus190009r44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women.","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"issue":"9883","key":"jus190009r45","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"27","key":"jus190009r46","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"jus190009r47","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1371\/journal.pctr.0020027","article-title":"Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial.","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS Clin Trials"},{"issue":"5","key":"jus190009r48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"jus190009r49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"10013","key":"jus190009r50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"jus190009r51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/jiw077","article-title":"A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine.","volume":"214","author":"Cottrell","year":"2016","journal-title":"J Infect Dis"},{"issue":"6","key":"jus190009r52","doi-asserted-by":"publisher","first-page":"e0157742","DOI":"10.1371\/journal.pone.0157742","article-title":"Adherence to pre-exposure prophylaxis for HIV prevention in a clinical setting.","volume":"11","author":"Montgomery","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"jus190009r53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/QAI.0000000000001538","article-title":"Plasma tenofovir levels to support adherence to TDF\/FTC preexposure prophylaxis for HIV prevention in MSM in Los Angeles, California.","volume":"76","author":"Landovitz","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"jus190009r54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","article-title":"An HIV preexposure prophylaxis demonstration project and safety study for young MSM.","volume":"74","author":"Hosek","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"jus190009r55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/2050-6511-15-77","article-title":"Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial.","volume":"15","author":"Mandala","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"jus190009r56","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cid\/ciu355","article-title":"Renal function of participants in the Bangkok tenofovir study\u2014Thailand, 2005-2012.","volume":"59","author":"Martin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"jus190009r57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/QAD.0000000000000156","article-title":"Changes in renal function associated with oral emtricitabine\/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.","volume":"28","author":"Solomon","year":"2014","journal-title":"AIDS"},{"issue":"2","key":"jus190009r58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jamainternmed.2014.6786","article-title":"Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.","volume":"175","author":"Mugwanya","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"8","key":"jus190009r59","doi-asserted-by":"publisher","first-page":"e23688","DOI":"10.1371\/journal.pone.0023688","article-title":"Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"jus190009r60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/cid\/civ324","article-title":"Effects of emtricitabine\/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind placebo-controlled trial.","volume":"61","author":"Mulligan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"jus190009r61","doi-asserted-by":"publisher","first-page":"e90111","DOI":"10.1371\/journal.pone.0090111","article-title":"Bone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofovir-emtricitabine or placebo in Botswana.","volume":"9","author":"Kasonde","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"jus190009r62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/jama.2014.8735","article-title":"Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.","volume":"312","author":"Mugo","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"jus190009r63","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000331995","article-title":"Targets for inhibition of HIV replication: entry, enzyme action, release and maturation.","volume":"55","author":"Sierra-Arag\u00f3n","year":"2012","journal-title":"Intervirology"},{"issue":"3","key":"jus190009r64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40265-015-0355-4","article-title":"Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.","volume":"75","author":"Krakower","year":"2015","journal-title":"Drugs"},{"issue":"18","key":"jus190009r65","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"issue":"21","key":"jus190009r66","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure.","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"jus190009r67","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1097\/QAI.0b013e3181fbcb4c","article-title":"Chemoprophylaxis for HIV prevention: new opportunities and new questions.","volume":"55","author":"Mayer","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"jus190009r68","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.","volume":"5","author":"Garc\u00eda-Lerma","year":"2008","journal-title":"PLoS Med"},{"issue":"5","key":"jus190009r69","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","article-title":"Effects of pre-exposure prophylaxis for the prevention of human immunodeficiency virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis.","volume":"67","author":"Traeger","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"jus190009r70","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.AOG.0000446855.78026.21","article-title":"ACOG Committee Opinion no 595: Committee on Gynecologic Practice: preexposure prophylaxis for the prevention of human immunodeficiency virus.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"jus190009r31","volume-title":"Pre-Exposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 178.","author":"Chou","year":"2018"},{"key":"jus190009r1","unstructured":"Centers for Disease Control and Prevention (CDC). Estimated HIV Incidence and Prevalence in the United States, 2010\u20132016. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-supplemental-report-vol-24-1.pdf. Published February 2019. Accessed April 16, 2019."},{"key":"jus190009r2","unstructured":"Centers for Disease Control and Prevention (CDC). Diagnoses of HIV Infection in the United States and Dependent Areas, 2017. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2017-vol-29.pdf. Published November 2018. Accessed April 16, 2019."},{"key":"jus190009r3","unstructured":"Centers for Disease Control and Prevention (CDC), US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States\u20142017 Update: A Clinical Practice Guideline. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf. Published March 2018. Accessed April 16, 2019."},{"key":"jus190009r4","unstructured":"Centers for Disease Control and Prevention (CDC). HIV and transgender people. CDC website. https:\/\/www.cdc.gov\/hiv\/group\/gender\/transgender\/index.html. 2019. Accessed April 16, 2019."},{"key":"jus190009r13","unstructured":"Gilead Sciences. Truvada prescribing information. Gilead Sciences website. https:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/hiv\/truvada\/truvada_pi.pdf. 2018. Accessed April 16, 2019."},{"key":"jus190009r15","unstructured":"Centers for Disease Control and Prevention (CDC). HIV and Youth. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/group\/age\/youth\/cdc-hiv-youth.pdf. Published April 2019. Accessed April 16, 2019."},{"key":"jus190009r18","unstructured":"Centers for Disease Control and Prevention (CDC). How you can prevent sexually transmitted diseases. CDC website. https:\/\/www.cdc.gov\/std\/prevention\/default.htm. 2016. Accessed April 16, 2019."},{"key":"jus190009r19","unstructured":"Centers for Disease Control and Prevention (CDC). Syringe services programs. CDC website. https:\/\/www.cdc.gov\/hiv\/risk\/ssps.html. 2018. Accessed April 16, 2019."},{"key":"jus190009r20","unstructured":"HIV\/AIDS, STIs and pregnancy. The Community Guide website. https:\/\/www.thecommunityguide.org\/topic\/hivaids-stis-and-pregnancy. Accessed April 16, 2019."},{"key":"jus190009r22","unstructured":"Centers for Disease Control and Prevention (CDC). US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States\u20142017 Update: Clinical Providers\u2019 Supplement. CDC website. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-provider-supplement-2017.pdf. Published March 2018. Accessed April 16, 2019."},{"key":"jus190009r23","unstructured":"Centers for Disease Control and Prevention (CDC). Pre-exposure prophylaxis (PrEP). CDC website. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html. 2018. Accessed April 16, 2019."},{"key":"jus190009r24","unstructured":"Centers for Disease Control and Prevention (CDC). NCHHSTP AtlasPlus. CDC website. https:\/\/www.cdc.gov\/nchhstp\/atlas\/. 2017. Accessed April 16, 2019."},{"key":"jus190009r28","unstructured":"BushS, MagnusonD, RawlingsMK, . ASM\/ICAAC: racial characteristics of FTC\/TDF for pre-exposure prophylaxis (PrEP) users in the US. National AIDS Treatment Advocacy Project website. http:\/\/www.natap.org\/2016\/HIV\/062216_02.htm. 2016. Accessed April 16, 2019."},{"key":"jus190009r71","unstructured":"World Health Organization (WHO). Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. WHO website. https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/. Published June 2016. Accessed April 16, 2019."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/22\/2203\/17644156\/jama_owens_2019_us_190009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T11:14:51Z","timestamp":1663672491000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.6390"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":71,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,6,11]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.6390","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,11]]}}}